Date: Tuesday, October 7th 2025 Location: TMC3 Collaborative Building (Atrium)7255 Helix Park Ave, Houston, TX 77030 8:00 a.m. Registration Opens 8:30 a.m. Opening Remarks ...
Read More
Dr. Kevin Slawin, MD, Founder, Chairman and CEO of Deliver Therapeutics, Inc., presented the company at this year’s Alexandria Seed Capital Platform’s Seed Catalyst Partnership Meeting held at The Alexandria…
GoodZ.Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse.Nature Medicine.2018
/wp-content/uploads/2024/07/GoodZ.Single-cell-developmental-classification-of-B-cell-precursor-acute-lymphoblastic-leukemia-at-diagnosis-reveals-predictors-of-relapse.Nature-Medicine.2018.pdf